Literature DB >> 23511900

DRESS syndrome induced by acenocoumarol with tolerance to warfarin and dabigatran: a case report.

Macarena Piñero-Saavedra1, Manuel Prados Castaño, Maria Ortega Camarero, Santiago Leguisamo Milla.   

Abstract

Drug reaction with eosinophlia and systemic symptoms (DRESS) syndrome describes a severe medication-induced adverse reaction, which shows skin, blood and solid-organ features. Up to 50 drugs have been described to cause DRESS. The main responsible drugs are carbamazepine and allopurinol. There are no previous reports associated with acenocoumarol. A 85-year-old white male, who was treated with acenocoumarol for the prevention of venous thromboembolism due to atrial fibrillation, presented 6 weeks later a maculopapular exanthema of the trunk and limbs as well as purple lesions and blisters on distal parts of his legs. Elevated creatinine, glucose, urea, International Normalized Ratio, gamma-glutamyl-transpeptidase (GGT) and eosinophilia levels were observed. Acenocoumarol was removed and enoxaparine, systemic corticosteroids, antihistamines were used as treatment with a favorable clinical evolution: 1 month later, the skin lesions had disappeared and laboratory parameters were normalized. Patch tests with warfarin and dabigatran were carried out. Two simple-blind, placebo-controlled oral challenges with warfarin and dabigatran were performed. Patch tests were negative, and single-blind, placebo-controlled oral challenges with warfarin and dabigatran were achieved without immediate or delayed reactions. We firstly describe a DRESS syndrome induced by acenocoumarol. Patch test was useful to assess alternative therapies. Tolerance to other anticoagulants (warfarin and dabigatran) was demonstrated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23511900     DOI: 10.1097/MBC.0b013e32835facc8

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

Review 1.  Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs.

Authors:  Kathrin Scherer Hofmeier
Journal:  Allergo J Int       Date:  2015-03-14

2.  Warfarin-Induced Skin Necrosis Despite Enoxaparin Bridging Therapy.

Authors:  Mohamed Wali; Muhammad T Latif; Mary Lockwood; Ayman Saeyeldin; Carolina Borz-Baba
Journal:  Cureus       Date:  2022-01-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.